FR2143163B2 - - Google Patents

Info

Publication number
FR2143163B2
FR2143163B2 FR7222310A FR7222310A FR2143163B2 FR 2143163 B2 FR2143163 B2 FR 2143163B2 FR 7222310 A FR7222310 A FR 7222310A FR 7222310 A FR7222310 A FR 7222310A FR 2143163 B2 FR2143163 B2 FR 2143163B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7222310A
Other languages
French (fr)
Other versions
FR2143163A2 (da
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2143163A2 publication Critical patent/FR2143163A2/fr
Application granted granted Critical
Publication of FR2143163B2 publication Critical patent/FR2143163B2/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7222310A 1971-06-22 1972-06-21 Expired FR2143163B2 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2920771A GB1381872A (en) 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation

Publications (2)

Publication Number Publication Date
FR2143163A2 FR2143163A2 (da) 1973-02-02
FR2143163B2 true FR2143163B2 (da) 1975-10-31

Family

ID=10287853

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7222310A Expired FR2143163B2 (da) 1971-06-22 1972-06-21

Country Status (9)

Country Link
JP (1) JPS5046820A (da)
AU (1) AU462722B2 (da)
CA (1) CA970685A (da)
DE (1) DE2229981C3 (da)
DK (1) DK134970B (da)
FR (1) FR2143163B2 (da)
GB (1) GB1381872A (da)
NL (1) NL176743C (da)
ZA (1) ZA723999B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2332663C2 (de) * 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
GB1520247A (en) * 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
EP0266443B1 (en) * 1986-11-03 1993-06-23 Allen W. Jacobs Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
IT1220979B (it) * 1981-06-04 1990-06-21 Lofarma Farma Lab Capsule contenenti un allergene e procedimento per la loro preparazione
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
EP1238661A1 (en) * 1999-10-12 2002-09-11 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US7744855B2 (en) 2000-06-27 2010-06-29 Vectura Limited Method of making particles for use in a pharmaceutical composition
EP2298279B1 (en) 2000-11-30 2018-11-14 Vectura Limited Pharmaceutical compositions for inhalation
ES2334642T5 (es) 2000-11-30 2016-03-07 Vectura Limited Partículas para usar en una composición farmacéutica
AR046225A1 (es) 2003-11-04 2005-11-30 Glaxo Group Ltd Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
CN104177448A (zh) 2005-02-10 2014-12-03 葛兰素集团有限公司 使用预分选技术制备乳糖的方法以及由此形成的药物制剂
EP3578169A1 (en) 2009-02-26 2019-12-11 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
ES2953293T3 (es) 2018-08-07 2023-11-10 Norton Waterford Ltd Aplicación de espectroscopia Raman para la fabricación de polvos para inhalación

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1122284A (en) * 1965-03-19 1968-08-07 Fisons Pharmaceuticals Ltd Inhalation device
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
JPS5046820A (da) 1975-04-25
DE2229981A1 (de) 1972-12-28
DK134970B (da) 1977-02-21
GB1381872A (en) 1975-01-29
CA970685A (en) 1975-07-08
NL176743C (nl) 1985-06-03
ZA723999B (en) 1973-06-27
AU462722B2 (en) 1975-07-03
NL7208207A (da) 1972-12-28
FR2143163A2 (da) 1973-02-02
DK134970C (da) 1977-07-18
NL176743B (nl) 1985-01-02
AU4380572A (en) 1974-01-03
DE2229981C3 (de) 1981-04-02
DE2229981B2 (de) 1980-07-03

Similar Documents

Publication Publication Date Title
DK134970C (da)
AR196074A1 (da)
JPS5243210B2 (da)
AU2658571A (da)
AU2691671A (da)
AU2742671A (da)
AU2684071A (da)
AU2564071A (da)
AU2894671A (da)
AU2941471A (da)
AU2952271A (da)
AU3005371A (da)
AU2503871A (da)
AU2654071A (da)
AR192311Q (da)
AU2880771A (da)
AU3038671A (da)
AU2684171A (da)
AU3025871A (da)
AU2875571A (da)
AU2854371A (da)
AU2963771A (da)
AU2706571A (da)
AU2724971A (da)
AU2940971A (da)